| Echinocandins: production and applications T Emri, L Majoros, V Tóth, I Pócsi Applied microbiology and biotechnology 97, 3267-3284, 2013 | 121 | 2013 |
| Significance of oral Candida infections in children with cancer M Alberth, L Majoros, G Kovalecz, E Borbás, I Szegedi, IJ Márton, C Kiss Pathology & oncology research 12, 237-241, 2006 | 78 | 2006 |
| Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model L Forgács, AM Borman, E Prépost, Z Tóth, G Kardos, R Kovács, A Szekely, ... Emerging microbes & infections 9 (1), 1160-1169, 2020 | 73 | 2020 |
| Genotypic and phenotypic properties of Candida parapsilosis sensu strictu strains isolated from different geographic regions and body sites A Tavanti, LAM Hensgens, S Mogavero, L Majoros, S Senesi, M Campa BMC microbiology 10, 1-11, 2010 | 72 | 2010 |
| In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae Z Tóth, L Forgács, JB Locke, G Kardos, F Nagy, R Kovács, A Szekely, ... Journal of Antimicrobial Chemotherapy 74 (12), 3505-3510, 2019 | 68 | 2019 |
| Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms R Kovács, A Bozó, R Gesztelyi, M Domán, G Kardos, F Nagy, Z Tóth, ... International journal of antimicrobial agents 47 (4), 304-310, 2016 | 59 | 2016 |
| Candida biofilm production is associated with higher mortality in patients with candidaemia E Vitális, F Nagy, Z Tóth, L Forgács, A Bozó, G Kardos, L Majoros, ... Mycoses 63 (4), 352-360, 2020 | 51 | 2020 |
| Fungal Quorum-Sensing Molecules: A Review of Their Antifungal Effect against Candida Biofilms R Kovács, L Majoros Journal of Fungi 6 (3), 99, 2020 | 48 | 2020 |
| In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris F Nagy, E Vitális, Á Jakab, AM Borman, L Forgács, Z Tóth, L Majoros, ... Frontiers in microbiology 11, 957, 2020 | 47 | 2020 |
| Protein phosphatase CaPpz1 is involved in cation homeostasis, cell wall integrity and virulence of Candida albicans C Adam, E Erdei, C Casado, L Kovacs, A Gonzalez, L Majoros, K Petrenyi, ... Microbiology 158 (5), 1258-1267, 2012 | 45 | 2012 |
| Correlation of posaconazole minimum fungicidal concentration and time–kill test against nine Candida species G Sóczó, G Kardos, PM McNicholas, E Balogh, L Gergely, I Varga, ... Journal of antimicrobial chemotherapy 60 (5), 1004-1009, 2007 | 42 | 2007 |
| Restriction Enzyme Analysis of Ribosomal DNA Shows that Candida inconspicua Clinical Isolates Can Be Misidentified as Candida norvegensis with Traditional … L Majoros, G Kardos, A Belak, A Maráz, L Asztalos, E Csánky, Z Barta, ... Journal of Clinical Microbiology 41 (11), 5250-5253, 2003 | 42 | 2003 |
| Farnesol increases the activity of echinocandins against Candida auris biofilms F Nagy, Z Tóth, L Daróczi, A Székely, AM Borman, L Majoros, R Kovács Medical mycology 58 (3), 404-407, 2020 | 40 | 2020 |
| The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model A Bozó, M Domán, L Majoros, G Kardos, I Varga, R Kovács Journal of Microbiology 54, 753-760, 2016 | 40 | 2016 |
| Fluconazole‐Resistant Pathogens Candida inconspicua and C. norvegensis: DNA Sequence Diversity of the rRNA Intergenic Spacer Region, Antifungal Drug … T Sugita, K Takeo, M Ohkusu, E Virtudazo, M Takashima, E Asako, ... Microbiology and immunology 48 (10), 761-766, 2004 | 40 | 2004 |
| Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms R Kovács, F Nagy, Z Tóth, A Bozó, B Balázs, L Majoros Letters in applied microbiology 69 (4), 271-278, 2019 | 35 | 2019 |
| Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence … R Kovács, Z Tóth, JB Locke, L Forgács, G Kardos, F Nagy, AM Borman, ... Microorganisms 9 (4), 863, 2021 | 33 | 2021 |
| Comparison of rates of fecal colonization with extended‐spectrum beta‐lactamase‐producing enterobacteria among patients in different wards, outpatients and medical students F Ebrahimi, J Mózes, J Monostori, O Gorácz, A Fésűs, L Majoros, ... Microbiology and immunology 60 (5), 285-294, 2016 | 32 | 2016 |
| In Vivo Applicability of Neosartorya fischeri Antifungal Protein 2 (NFAP2) in Treatment of Vulvovaginal Candidiasis R Kovács, J Holzknecht, Z Hargitai, C Papp, A Farkas, A Borics, L Tóth, ... Antimicrobial Agents and Chemotherapy 63 (2), 10.1128/aac. 01777-18, 2019 | 31 | 2019 |
| Comparison of In Vitro and Vivo Efficacy of Caspofungin Against Candida parapsilosis, C. orthopsilosis, C. metapsilosis and C. albicans R Földi, R Kovács, R Gesztelyi, G Kardos, R Berényi, B Juhász, J Szilágyi, ... Mycopathologia 174, 311-318, 2012 | 30 | 2012 |
